Dual targeting of TGF-β and PD-L1 via a bifunctional anti-PD-L1/TGF-βRII agent: status of preclinical and clinical advances
=============================================================================================================================

* Hanne Lind
* Sofia R Gameiro
* Caroline Jochems
* Renee N. Donahue
* Julius Strauss
* James L Gulley, MD,
* Claudia Palena
* Jeffrey Schlom